Abstract
Type VII collagen is the predominant, if not the exclusive, component of the anchoring fibrils, attachment structures stabilizing the association of the cutaneous basement membrane to the underlying dermis. In the skin, type VII collagen is synthesized by both dermal fibroblasts and epidermal keratinocytes. Alterations in the type VII collagen protein structure or lack of its expression due to mutations in the corresponding gene COL7A1 are the hallmark of dystrophic epidermolysis bullosa, a mechano-bullous skin disease characterized by extreme fragility of the skin and leading to development of sub-lamina densa blisters. In this study, we have examined whether the additive effect of TGF-ß with TNF-α on type VII collagen gene expression is exerted at the transcriptional level by activation of the corresponding a promoter. Specifically, we demonstrate that the TNF-α effect is mediated by NF-kB1/RelA (p50/p65) and RelA/RelA (p65/p65) NF-kB complexes binding the TNF-α response element (TaRE) located in the region [7252/7230], with RelA acting as the transcriptional activator. We provide definitive evidence for the role of both TGF-ß and TNF-α response elements as enhancer sequences, functioning in the context of a heterologous promoter in an additive manner in response to TGF-ß and TNF-α. This study provides the functional interaction between the two immediate-early transcription factors, SMAD and NF-kB, to activate the expression of an extracellular matrix-related gene, COL7A1.
Key words: Type VII collagen; TGF-Beta; SMAD; NF-kB; TNF-α
Copyright © 2014 by The American Society for BioMedicine and BM-Publisher, Inc.
- Massague J, Wotton D. Transcriptional control by the TGF-β/SMAD signaling system. EMBO J 2000;19:1745-1754.
- Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992; 359: 693-699.
- Piek E, Heldin C.H, ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J. 1999; 13: 2105-2124.
- Persson U, Izumi H, Souchelnytskyi S, Itoh S, Grimsby S, Engstrom U, et al. The L45 loop in type I receptors for TGF-β family members is a critical determinant in specifying SMAD isoform activation. FEBS Lett. 1998;434:83-87.
- Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?, Annu Rev Immunol 2001;19:163-96.
- Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact, Cell 1990;63: 251-8.
- Alexopoulou L, Pasparakis M, Kollias G. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling, Eur J Immunol 1997;27:2588-92.
- Yousif NG. Fibronectin promotes migration and invasion of ovarian cancer cells through up‐regulation of FAK–PI 3 K/A kt pathway. Cell biology international 2014;38 (1):85-91.
- Eissner G, Kolch W, Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system, Cytokine Growth Factor Rev 2004;15:353-66.
- Mitoma H, Horiuchi T, Tsukamoto H, et al. Mechanisms for cytotoxic effects of anti-TNF agents on transmembrane TNF-expressing cells: comparison among infliximab, etanercept and adalimumab. Arthritis Rheum 2008;58:1248-57.
- Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha, Nature 1997;385:733-6.
- Utsumi T, Takeshige T, Tanaka K, et al. Transmembrane TNF (pro-TNF) is palmitoylated, FEBS Lett 2001;500:1-6.
- Atsushi Kon, Laurence Vindevoghel, David J Kouba, et al. Cooperation between SMAD and NF-kB in growth factor regulated type VII collagen gene expression. Oncogene 1999;18:1837-1844.
- Kim RH, Wang D, Tsang M,et al:A novel smad nuclear interacting protein, SNIP1,suppresses p300-dependent TGF-beta signal transduction.Genes Dev 2000;14:1605±1616.
- Kouba DJ, Chung KY, Nishiyama T,et al:Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription inhuman dermal Fibroblasts.J Immunol 1999;162:4226-4234.
- Zhang W, Ou J, Inagaki Y, Greenwel P, Ramirez F: Synergistic cooperationbetween Sp1 and Smad3/Smad4 mediates transforming growth factor beta1stimulation of alpha 2(I)-collagen (COL1A2) transcription.J Biol Chem 2000;275:39237-39245.
- Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest. 1992;89:1662–1668.
- Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, Moustakas A: Role ofSmad proteins and transcription factor Sp1 in p21 (Waf1/Cip1) regulation bytransforming growth factor-beta.J Biol Chem 2000;275:29244-29256.
- Massague J, Wotton D: Transcriptional control by the TGF-beta/Smad signalingsystem.EMBO J 2000;19:1745-1754.
- Gauldie J, Jordana M, Cox G, et al. Fibroblasts and other structural cells in airway inflammation. Am Rev Respir Dis. 1992;145:S14–S17.
- Zhang S, Smartt H, Holgate ST, Roche WR. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: an in vitro co-culture model of airway remodeling in asthma. Lab Invest. 1999;79:395–405.
- Li QD, Tseng SCG. Three patterns of cytokine expression potentially involved in epithelial-fibroblast interactions of human ocular surface. J Cell Physiol. 1995;163:61–79.
- Ravanti L, Häkkinen L, Larjava H, Saarialho-Kere U, Foschi M, et al. Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 1999;274: 37292–37300.
- Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, et al. Smad-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J 2002;21:6473–6482.
- Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. J Immunol 1996;156:275–283.
- Leivonen S-K, Ala-aho R, Koli K, Grenman R, Peltonen J, et al. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 2006;25: 2588–2600.
- Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest. 1992;90:1479–1485.
- Leivonen S-K, Häkkinen L, Liu D, Kähäri V-M. Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-β-induced expression of connective tissue growth factor in human fibroblasts. J Invest Dermatol 2005;124:1162–1169.
- Gauldie J, Cox G, Jordana M, Ohno I, Kirpalani H. Growth and colony-stimulating factors mediate eosinophil fibroblast interactions in chronic airway inflammation. Ann NY Acad Sci. 1993;19:83–90.
- Yuan W, Varga J. Transforming growth factor-β repression of matrix metalloproteinase-1 in dermal fibroblasts involves smad3. J Biol Chem 2001;276: 38502–38510.
- Leonardi A, Borghesan F, DePaoli M, Plebani M, Secchi AG. Procollagens and fibrogenic cytokines in vernal keratoconjunctivitis. Exp Eye Res 1998;67:105–112.
- Calder VL, Jolly G, Hingorani M, et al. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease. Clin Exp Allergy 1999;29:1214–1222.
3. Purchase this article at rate $33.00
For any technique error please contact us
Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,...
Review Article
DOI: http://dx.doi.org/10.18081/2333-5106/014-01/56-66
American Journal of BioMedicine 2014, Volume 2, Issue 2, pages 106-115
Received 21 January 2014; accepted 13, February 2014, Published June 02, 2014
How to cite this article
Susan De Curtis SD, Aderaye S, Bower J, et al. The additive effect of TGF-ß with TNF-α on type VII collagen gene expression to activate the expression of an extracellular matrix-related gene. American Journal of BioMedicine 2014;2(2):106-1115.
Case report outline
1. Abstract
2. Keywords
3. Introduction
4. Methods
5. Results
6. Discussion
7. References